Dimitry Ofengeim

Dimitry Ofengeim

Company: Sanofi

Job title: Precision Neurology and Neuroinflammation Head

Seminars:

Live Q&A With Your Expert Speakers 2:45 pm

Read more

day: Track A - Day 2 pm

Delving Into the Interface of Neuroinflammation & Neurodegeneration 2:15 pm

Exploring the mechanisms of action for RIPK1-medicated neuroinflammation in CNS diseases, focusing on ALS,MS and beyond. Reviewing RIPK1 biology and disease-associated mutations in RIPK1 signalling pathways Pioneering applications of these RIPK1 inhibitors for the treatment of monogenic and polygenic neurodegenerative disorders Early discovery work underway for future endeavoursRead more

day: Track A - Day 2 pm

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.